Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels
Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 169-184.e13
Open Access | Times Cited: 529
Coronavirus vaccine development: from SARS and MERS to COVID-19
Yen-Der Li, Wei-Yu Chi, Jun-Han Su, et al.
Journal of Biomedical Science (2020) Vol. 27, Iss. 1
Open Access | Times Cited: 428
Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience
Abdullah Algaissi, Naif Khalaf Alharbi, Mazen Hassanain, et al.
Journal of Infection and Public Health (2020) Vol. 13, Iss. 6, pp. 834-838
Open Access | Times Cited: 421
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial
Pedro M. Folegatti, Mustapha Bittaye, Amy Flaxman, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 7, pp. 816-826
Open Access | Times Cited: 224
Vaccines for COVID-19
John S. Tregoning, E. Sherwood Brown, Hannah M. Cheeseman, et al.
Clinical & Experimental Immunology (2020) Vol. 202, Iss. 2, pp. 162-192
Open Access | Times Cited: 215
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao, Shan Zhao, Junxian Ou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 212
COVID-19: Knowns, Unknowns, and Questions
Stuart Weston, Matthew B. Frieman
mSphere (2020) Vol. 5, Iss. 2
Open Access | Times Cited: 188
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
Eriko Padron-Regalado
Infectious Diseases and Therapy (2020) Vol. 9, Iss. 2, pp. 255-274
Open Access | Times Cited: 175
COVID-19 vaccine confidence and hesitancy among health care workers: A cross-sectional survey from a MERS-CoV experienced nation
Mazin Barry, Mohamad‐Hani Temsah, Abdullah Alhuzaimi, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0244415-e0244415
Open Access | Times Cited: 112
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Ranjan K. Mohapatra, Lucia Pintilie, Venkataramana Kandi, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 5, pp. 1187-1208
Open Access | Times Cited: 127
Potential zoonotic sources of SARS‐CoV‐2 infections
Wendy K. Jo, Edmilson Ferreira de Oliveira-Filho, Andrea Rasche, et al.
Transboundary and Emerging Diseases (2020) Vol. 68, Iss. 4, pp. 1824-1834
Open Access | Times Cited: 110
A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques
Neeltje van Doremalen, Elaine Haddock, Friederike Feldmann, et al.
Science Advances (2020) Vol. 6, Iss. 24
Open Access | Times Cited: 105
New viral vectors for infectious diseases and cancer
Emanuele Sasso, Anna Morena D’Alise, Nicola Zambrano, et al.
Seminars in Immunology (2020) Vol. 50, pp. 101430-101430
Open Access | Times Cited: 80
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals
Haleema Alserehi, Ada Alqunaibet, Jaffar A. Al‐Tawfiq, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 99, Iss. 3, pp. 115273-115273
Open Access | Times Cited: 74
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets
Glenn A. Marsh, Alexander J. McAuley, Gough G. Au, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 55
Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection
Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
Current Medicinal Chemistry (2021) Vol. 29, Iss. 1, pp. 4-18
Closed Access | Times Cited: 55
Adenovirus-based vaccines—a platform for pandemic preparedness against emerging viral pathogens
Lynda Coughlan, Eric J. Kremer, Dmitry M. Shayakhmetov
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1822-1849
Open Access | Times Cited: 44
Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, et al.
Nutrients (2022) Vol. 14, Iss. 16, pp. 3417-3417
Open Access | Times Cited: 39
COVID-19 vaccine confidence and hesitancy among healthcare workers: a cross-sectional survey from a MERS-CoV experienced nation
Mazin Barry, Mohamad‐Hani Temsah, Abdullah Alhuzaimi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58
Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection
Kun Li, Zhuo Li, Christine Wohlford-Lenane, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 51
Vaccine Preventable Zoonotic Diseases: Challenges and Opportunities for Public Health Progress
Ann Carpenter, Michelle A. Waltenburg, Aron J. Hall, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 993-993
Open Access | Times Cited: 29
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 335-346
Open Access | Times Cited: 28
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
Pedro M. Folegatti, Daniel Jenkin, Susan Morris, et al.
Vaccine (2022) Vol. 40, Iss. 35, pp. 5248-5262
Open Access | Times Cited: 28
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
Diego Cantoni, Craig Wilkie, Emma M. Bentley, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
A review of vaccine effects on women in light of the COVID-19 pandemic
Wen‐Han Chang
Taiwanese Journal of Obstetrics and Gynecology (2020) Vol. 59, Iss. 6, pp. 812-820
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top